Search for: "Block v. Ebay, Inc." Results 121 - 140 of 145
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
15 Apr 2010, 2:19 pm by Jim Harper
Justice O’Connor wrote the 8-0-1 1991 opinion in Feist Publications, Inc. v. [read post]
2 May 2008, 7:00 am
Landmark IP implications for universities: University of Western Australia v Gray: (IPRoo), (Managing Intellectual Property), (The Age), The latest edition of US Trade Representative’s ‘Special 301 Report’: (Ars Technica), (Ars Technica), (IAM), (Intellectual Property Watch), (Patry Copyright Blog), (Managing Intellectual Property), (Patent Docs), (IP Law360), Court rejects RIAA ‘making available’ theory: Atlantic v Howell:… [read post]
29 Sep 2013, 5:30 am by Barry Sookman
Becomes Canada’s Longest-Serving Chief Justice http://t.co/WxpKIS9o3n -> Life on the Social Media Front Line: The legal and ethical challenges facing Online Community Managers http://t.co/YD8WpEJJZj -> eBay Not Liable for Technical Glitch When Seller Doesn't Set Reserve Price — D'Agostino v. eBay http://t.co/2epESgQmu0 -> Court Upholds Doocing For Snarky Facebook Post — Rodriquez v. [read post]
5 Mar 2009, 2:00 am
(Ars Technica) RIAA – Shahanda Moursy sues RIAA for fraud, abuse and legal sham (TorrentFreak) Tenenbaum, Joel – Defence team’s unorthodox tactics in illegal file-swapping case incurs judge’s displeasure (Ars Technica)   US Trade Marks – Decisions District Court New Hampshire: Domaining registrar defeats cybersquatting lawsuit: Philbrick v eNom, Inc (Technology & Marketing Law Blog) (The Trademark Blog) District… [read post]
25 Jan 2008, 1:00 am
: (Generic Pharmaceuticals & IP),Arava (Leflunomide) - Sanofi-Aventis loses bid to dismiss Louisiana Wholsesale Drug Co's antitrust claims accusing S-A of unlawfully blocking generic competition for Arava by filing a sham Citizen Petition with the USFDA: (IP Law360),Ciprofloxacin - CIPLA issued notice by National Pharmaceutical Pricing Authority for allegedly overpricing its antibiotic Ciprofloxacin (especially of note because CIPLA is… [read post]
30 Jan 2009, 7:00 pm
(Intellectual Property Directions) USPTO to hold Innovation Week 22-27 June (Patent Docs) US-Korea adopt patent prosecution highway (Law360) (Patent Docs) (Managing Intellectual Property) Obama’s environmentally-friendly present for supporters of the patent system (IAM) How to cut legal costs and improve results in troubled times (IP Frontline) PatentCluster – free clustering based patent search engine (Patent Baristas) Requesting withdrawal of the finality of an office action… [read post]
29 Aug 2008, 1:25 pm
– Discussion of IPFrontline.com article ‘Understanding Intellectual Property Value’: (IP finance), How to make sure your IP strategy plan is not doomed to failure: (IP Asset Maximizer Blog) Improve venture capital returns with IP portfolio management: (Ezine @rticles)   Global - Trade Marks / Domain Names / Brands Trade mark strategy – counterintuitive names: (IP Thinktank), ICANN Intellectual Property Constituency paper on sunrise mechanisms for… [read post]
18 Jul 2008, 8:34 am
: (Patent Circle), Tanzania to conduct study on impact of counterfeit medicines: (Afro-IP), US: New rules on generic biological medicines under US Congressional debate: (Intellectual Property Watch), Pharma & Biotech - Products Acular (Ketorolac) – US: CAFC rules against Apotex reverse doctrine of equivalents: Roche Palo Alto & Allergan, Inc v Apotex: (Patent Circle), Carbatrol (Carbamazapine) – US: Federal judge allows Corepharma to seek DJ… [read post]
22 Mar 2008, 2:00 am
: (IPBiz),US: Two remaining challenged WARF embryonic stem cell patents upheld in ex parte reexamination: (Holman's Biotech IP Blog), Pharma & Biotech - ProductsAricept (Donepezil) – USV wins appeal against USPTO decision: (Spicy IP),Celerex (Celecoxib) – CAFC decision in Celebrex patents dispute between Pfizer and Teva will cut patent term by one and a half years: (Patent Baristas), Inersan – Ranbaxy in-licenses Inersan to CD Pharma to market in India and… [read post]
2 Aug 2008, 12:54 am
: (Holman’s Biotech IP Blog), Daiichi’s open offer for 20% in Ranbaxy awaits Sebi nod: (GenericsWeb), Australia/India: Strides shows thumbs up for Indian generic industry acquiring controlling interest in Ascent: (Spicy IP), Europe: Significant date ahead for EU Paediatric Regulation: (SPC Blog), India: Grave diggers, ‘immoral’ patent and the National Biotech Regulatory Authority: (Spicy IP), UK: Monster trade mark infringement case: court reveals its thinking… [read post]
5 Oct 2018, 7:43 pm by Schachtman
DePuy Orthopaedics, Inc., Nos. 16-11051, et al., 2018 U.S. [read post]
13 Jun 2008, 3:40 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: ECJ rules trade mark holders cannot stop honest comparative advertising: O2 Holdings Limited and O2 (UK) Limited v Hutchinson 3G UK Limited: (Out-Law), (Catch Us If You Can!!!) [read post]
11 Apr 2008, 9:00 am
No problem…: Lundbeck A/S v Generics UK Ltd & Ors: (IPKat), Exelon (Rivastigmine Tartrate) – Dr Reddy’s and Novartis settle Exelon patent dispute: (Therapeutics Daily), GeneMaker – Codon Devices, Blue Heron Biotechnology settle patent suit over gene synthesis platform: (Patent Docs), Glucophage (Metformin) – Depomed settles patent litigation against IVAX: (SmartBrief), (IP Law360), (GenericsWeb), Lexapro… [read post]
22 Oct 2009, 2:59 pm
See, e.g., Lockheed Martin Corp. v. [read post]
12 Sep 2008, 2:33 pm
: Nine v IceTV: (International Law Office)   Benelux Some new rules of the Director-General of the Benelux Organisation for Intellectual Property with regard to trade mark filings refused on absolute grounds and withdrawal of oppositions: (Class 46)   Brazil Brazil exports agricultural technology to developing world: (IP tango)   Canada Conservatives website faces claims of copyright infringement: (Michael Geist), Canada’s trade mark opposition practice… [read post]
25 Oct 2021, 1:31 pm by Aaron Moss
One of the few remaining originals will set you back at least $400 on eBay. 3. [read post]